3.3700
30-April-25 10:27:44
15 minutes delayed
Stocks
-0.1000
-2.88%
Today's range
3.3700 - 3.3700
ISIN
N/A
Source
NASDAQ
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Italy for the Treatment of Individuals with Multiple System Atrophy
25 Jan 2023 07:25:00 By Nasdaq GlobeNewswire